Litigation Details for AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)
✉ Email this page to a colleague
AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-08-08 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 7,851,502; 7,919,598; 8,221,786; 8,361,972; 8,501,698; 8,685,934; 8,716,251 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. ScieGen Pharmaceuticals, Inc.
Details for AstraZeneca AB v. ScieGen Pharmaceuticals, Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-08-08 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,934; 7,851,502; 8,221,786; 8,361,972…8,716,251; 7,919,598 ; 8,501,698. (Attachments: # 1 Patent/Trademark Report)(mpb) (Entered: 08/08/2024) … 8 August 2024 1:24-cv-00923 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |